Literature DB >> 20814833

Vertical transmission of HIV-an update.

Mamatha M Lala1, Rashid H Merchant.   

Abstract

One of the greatest successes in AIDS research to date has by far been the discovery of successful interventions that interrupt the transmission of HIV from mother to child. It is however important to note that these successes have occurred largely in countries with great resources and the least burden of perinatal transmission of HIV. In the developing world wherein currently 95% of vertical transmission of HIV occurs, it is highly condemnable that still every minute an infected infant is said to be born in spite of the fact that vertical transmission is largely preventable, mainly because translating knowledge into practice is not always possible or feasible; This has led to a continuous growing numbers of children with HIV, thereby making pediatric HIV a looming problem rapidly draining the already burdened health care system of these countries. It is the need of the hour to appropriately address the challenges to achieve zero percent transmission of HIV from an infected mother to her child thereby giving a hope for an AIDS-free new generation worldwide.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20814833     DOI: 10.1007/s12098-010-0184-0

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  28 in total

1.  Antiretroviral resistance mutations among pregnant human immunodeficiency virus type 1-infected women and their newborns in the United States: vertical transmission and clades.

Authors:  P Palumbo; B Holland; T Dobbs; C P Pau; C C Luo; E J Abrams; S Nesheim; P Vink; R Respess; M Bulterys
Journal:  J Infect Dis       Date:  2001-09-20       Impact factor: 5.226

2.  Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission.

Authors:  Ellen R Cooper; Manhattan Charurat; Lynne Mofenson; I Celine Hanson; Jane Pitt; Clemente Diaz; Karen Hayani; Edward Handelsman; Vincent Smeriglio; Rodney Hoff; William Blattner
Journal:  J Acquir Immune Defic Syndr       Date:  2002-04-15       Impact factor: 3.731

3.  Strategy for preventing vertical transmisssion of HIV : Bombay experience.

Authors:  R H Merchant; K Damania; I S Gilada; R V Bhagwat; J S Karkare; J S Oswal; S R Merchant; S Changedia
Journal:  Indian Pediatr       Date:  2001-02       Impact factor: 1.411

4.  Transmission rates in consecutive pregnancies exposed to single-dose nevirapine in Soweto, South Africa and Abidjan, Côte d'Ivoire.

Authors:  Neil A Martinson; Didier K Ekouevi; Francois Dabis; Lynn Morris; Pumla Lupodwana; Besigin Tonwe-Gold; Puleng Dhlamini; Renaud Becquet; Jan G Steyn; Valériane Leroy; Ida Viho; Glenda E Gray; James A McIntyre
Journal:  J Acquir Immune Defic Syndr       Date:  2007-06-01       Impact factor: 3.731

5.  Decay of K103N mutants in cellular DNA and plasma RNA after single-dose nevirapine to reduce mother-to-child HIV transmission.

Authors:  Shayne Loubser; Peter Balfe; Gayle Sherman; Scott Hammer; Louise Kuhn; Lynn Morris
Journal:  AIDS       Date:  2006-04-24       Impact factor: 4.177

6.  Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP.

Authors:  Susan H Eshleman; Donald R Hoover; Shu Chen; Sarah E Hudelson; Laura A Guay; Anthony Mwatha; Susan A Fiscus; Francis Mmiro; Philippa Musoke; J Brooks Jackson; Newton Kumwenda; Taha Taha
Journal:  J Infect Dis       Date:  2005-06-01       Impact factor: 5.226

7.  Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa?

Authors:  Valériane Leroy; Charlotte Sakarovitch; Mario Cortina-Borja; James McIntyre; Hoosen Coovadia; Francois Dabis; Marie-Louise Newell; J Saba; G Gray; Ch Ndugwa; Ch Kilewo; A Massawe; P Kituuka; P Okong; A Grulich; H von Briesen; J Goudsmit; G Biberfeld; G Haverkamp; G J Weverling; J M A Lange
Journal:  AIDS       Date:  2005-11-04       Impact factor: 4.177

8.  Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy.

Authors:  Gonzague Jourdain; Nicole Ngo-Giang-Huong; Sophie Le Coeur; Chureeratana Bowonwatanuwong; Pacharee Kantipong; Pranee Leechanachai; Surabhon Ariyadej; Prattana Leenasirimakul; Scott Hammer; Marc Lallemant
Journal:  N Engl J Med       Date:  2004-07-09       Impact factor: 91.245

9.  Lopinavir/ritonavir in pregnancy.

Authors:  Susan S Roberts; Marisol Martinez; Deborah L Covington; Richard A Rode; Mary V Pasley; William C Woodward
Journal:  J Acquir Immune Defic Syndr       Date:  2009-08-01       Impact factor: 3.731

10.  Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis.

Authors:  Anna Coutsoudis; Francois Dabis; Wafaie Fawzi; Philippe Gaillard; Geert Haverkamp; D Robert Harris; J Brooks Jackson; Valerie Leroy; Nicolas Meda; Philippe Msellati; Marie-Louise Newell; Ruth Nsuati; Jennifer S Read; Stefan Wiktor
Journal:  J Infect Dis       Date:  2004-05-26       Impact factor: 5.226

View more
  4 in total

1.  Woman with congenital HIV infection and medication-induced Fanconi syndrome.

Authors:  Christian Mabry; Myra A Kleinpeter; D Luke Glancy
Journal:  Proc (Bayl Univ Med Cent)       Date:  2012-01

2.  Prevention on parent to child transmission of HIV - what is new?

Authors:  Mamatha M Lala; Rashid H Merchant
Journal:  Indian J Pediatr       Date:  2012-10-19       Impact factor: 1.967

3.  [Postpartum women with unknown HIV status in Lubumbashi, DR Congo: proportion and determinants].

Authors:  Albert Mwembo-Tambwe A Nkoy; Prosper Kalenga Muenze Kayamba; Philippe Donnen; Faustin Chenge Mukalenge; Perrine Humblet; Michèle Dramaix; Pierre Buekens
Journal:  Pan Afr Med J       Date:  2012-06-08

4.  Research protocol for an epidemiological study on estimating disease burden of pediatric HIV in Belgaum district, India.

Authors:  Anju Sinha; Anita Nath; Rajeev Sethumadhavan; Shajy Isac; Reynold Washington
Journal:  BMC Public Health       Date:  2016-05-26       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.